PTH1R | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

9 results for “PTH1R”

Trials

Not yet recruiting

Risk Factors for Tooth Eruption Diseases

50 participants · First posted May 14, 2026

Efficacy and Safety of XH02 for the Treatment of Hypoparathyroidism

6 participants · First posted Sep 29, 2025

Drugs

PTH1R target (Septerna)

Anti-PTH1R antagonist monoclonal antibody

PTHR1 agonist (hypoparathyroidism)

News

Septerna Initiates Phase 1 Trial of Oral PTH1R Agonist SEP-786 for Hypoparathyroidism

Septerna Halts Phase 1 Trial of SEP-786 for Hypoparathyroidism Due to Safety Concerns

Septerna Appoints Keith Gottesdiener as Board Director and R&D Committee Chair